Kempf W, Haeffner A C, Mueller B, Panizzon R G, Burg G
Department of Dermatology, University Hospital of Zurich, Switzerland.
Am J Dermatopathol. 1998 Oct;20(5):478-82. doi: 10.1097/00000372-199810000-00009.
The diagnosis of lymphoproliferative and melanocytic skin lesions is one of the most vexing problems in dermatopathology, a problem that is compounded by the far-reaching therapeutic and psychosocial consequences of the diagnosis for both patient and physician. On the occasion of a self-assessment slide seminar held during a dermatopathology meeting, 30 unusual lymphoproliferative and melanocytic lesions, each provided with four differential diagnoses, were evaluated by "expert pathologists" and other participants ("nonexperts") of the slide seminar. The final diagnosis was pinpointed by the majority of the experts in 16 of 30 cases (56%). The group of experts returned an unanimous decision on the diagnosis in only 2 of the 30 cases (7%). In contrast to the expert group, the preferred diagnoses given by the nonexperts showed a wider range. In 20 of 30 cases (66%), the final diagnosis could only be established after consideration of clinical, histologic, immunophenotypic, and molecular features. Our findings agree with the results of recent studies indicating quite a high degree of discordance among expert pathologists. The discordance between experts and, to a higher extent, nonexperts may have some crucial consequences for dermatopathology. Full agreement on diagnosis, particularly in unusual skin lesions, cannot be achieved only by an accumulation of expertises. Instead of relying on one single finding or diagnostic procedure ("gold standard") as the main criterion upon which to base a diagnosis, the diagnoses become more reliable if based on the integration of several factors including an evaluation of clinical and histomorphologic features and immunophenotypic and molecular findings ("diagnostic elements"), particularly in the field of lymphoproliferative and melanocytic lesions. In addition, a continuous retrospective work-up of difficult or unusual cases is recommended to ensure a long-term improvement in diagnostic reliability.
淋巴增生性和黑素细胞性皮肤病变的诊断是皮肤病理学中最棘手的问题之一,对于患者和医生而言,该诊断所带来的深远治疗及心理社会影响使这一问题变得更加复杂。在一次皮肤病理学会议期间举办的自我评估幻灯片研讨会上,“专家病理学家”以及该幻灯片研讨会的其他参与者(“非专家”)对30例不常见的淋巴增生性和黑素细胞性病变进行了评估,每个病例都提供了四种鉴别诊断。30例病例中有16例(56%)的最终诊断由大多数专家确定。专家小组在30例病例中仅有2例(7%)给出了一致的诊断意见。与专家小组不同,非专家给出的首选诊断范围更广。30例病例中有20例(66%)仅在综合考虑临床、组织学、免疫表型和分子特征后才能确定最终诊断。我们的研究结果与近期研究结果一致,这些研究表明专家病理学家之间存在相当高程度的诊断不一致。专家与非专家之间的不一致,尤其是非专家之间更高程度的不一致,可能会给皮肤病理学带来一些关键影响。仅通过积累专业知识无法在诊断上达成完全一致,尤其是在不常见的皮肤病变中。诊断不应仅依赖单一发现或诊断程序(“金标准”)作为主要依据,而如果基于整合包括临床和组织形态学特征评估、免疫表型和分子发现(“诊断要素”)等多个因素,诊断会变得更可靠,特别是在淋巴增生性和黑素细胞性病变领域。此外,建议对疑难或不常见病例进行持续的回顾性分析,以确保长期提高诊断可靠性。